Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
We compare high-return candidates for Roth IRA indexing, analyzing volatility, fees, and potential tax-free compounding effects.
28,037 articlesA major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Mortgage demand dropped sharply in the latest MBA survey, with refinances leading the decline as rates trended higher...
New market data shows most active managers fail to beat the S&P 500 over extended periods. This story explains the fo...
Retirees are quietly piling into IDV, the iShares International Select Dividend ETF, chasing steady income and intern...
Market swings challenge even the best investors. This year, the wealthiest have programmed their portfolios with a di...
In 2026, XLK’s cap-driven approach has quietly outpaced FTEC. Concentration limits are redirecting capital toward sem...
Investors weighing a gold-only ETF versus a silver-backed ETF face a tradeoff: gold offers lower volatility and costs...
When a major institutional investor trims a fund like COMT, the move can ripple through risk, liquidity, and prices. ...
A small group of stocks power long-term wealth, while the majority underperform. This report explains how to find the...
AI-driven cyber threats are accelerating, but the WisdomTree Cybersecurity Fund remains under pressure as its index c...
Choosing the right international ETF matters for your long-term plan. This guide dives into Schwab's SCHE and State S...
In the demanding world of entertainment and performance, schedules are harsh and pay can be unpredictable. This artic...